
Methyldopa tablets
Form: Tablets
Strength: 250 mg, 500 mg, and 750 mg
Reference Brands: Aldomet(US)
Category: Hypertension
Methyldopa tablets, marketed as Aldomet, are approved in the US by the FDA and in the EU via EMA for managing hypertension, particularly during pregnancy. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews clinical trial and quality data to ensure safety and effectiveness, while EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Adhering to regional requirements supports timely approval, safe medication use, and global availability to help manage hypertension effectively worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Antithymocyte Globulin (ATG) powder for injection
Strength: 250mg/5ml
Form: Lyophilized powder
Reference Brands: Thymoglobulin(US & EU)
View Details Get EnquiryHydralazine tablets
Strength: 10 mg, 25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Apresoline(US & Eu)
View Details Get EnquiryClonidine Patch
Strength: 0.1 mg/24 hours, 0.2 mg/24 hours, 0.3 mg/24 hours
Form: transdermal patch
Reference Brands: Catapres(US)
View Details Get EnquiryClonidine tablets
Strength: 0.1 mg, 0.2 mg, 0.3 mg
Form: Tablets
Reference Brands: Catapres(US)
View Details Get Enquiry